Determination of pipecolic acid in serum or plasma by solid-phase extraction and isotope dilution mass spectrometry.
The determination of pipecolic acid in serum or plasma by positive chemical ionization gas chromatography/mass spectrometry is assessed. This quantitative method involves stable isotope dilution and cation-exchange solid-phase extraction. Several derivatives of pipecolic acid and its octadeuterated analogue were investigated for their mass spectrometric characteristics. The heptafluorobutyric methyl ester derivatives afford optimal resolution on gas chromatography of biological extracts. Moreover, the derivatizing reagent (methanolic HCl) allows a combined elution and derivatization. Selected ion monitoring is performed on the [M + H]+ ions of both analyte and internal standard, at m/z 340 and 348, respectively. Serum or plasma samples from healthy subjects and patients suspected of peroxisomal diseases have been examined.
Van Bocxlaer
J F
JF
Laboratoria voor Medische Biochemie en Klinische Analyse, Rijksuniversiteit Gent, Belgium.
Verhaeghe
B J
BJ
Wauters
A E
AE
De Marez
W D
WD
Thienpont
L M
LM
De Leenheer
A P
AP
D002648:Child; D002675:Child, Preschool; D002852:Chromatography, Ion Exchange; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007223:Infant; D013058:Mass Spectrometry; D008661:Metabolism, Inborn Errors / Q000097:blood; D008830:Microbodies / Q000378:metabolism; D010875:Pipecolic Acids / Q000097:blood*; D011865:Radioisotope Dilution Technique
D010875:Pipecolic Acids